Lilly and Mylan Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Lilly, Mylan, as well as Flexion Therapeutics. Editor’s Note: Editor’s Note: This article was updated…

EMA Expands List of Excipients That Require Disclosure
By

By
The European Medicines Agency (EMA) and the European Commission have updated the annex to the European Commission guideline on excipients in the labelling and package leaflet of medicinal products for…

Emergent Completes Acquisition of GSK’s Anthrax Drug
By

By
Emergent BioSolutions, a specialty pharmaceutical company and contract manufacturing organization, has completed its acquisition of GlaxoSmithKline’s raxibacumab, a fully human monoclonal antibody approved by the US Food and Drug Administration…

Gilead Licenses HIV Drug to Medicines Patent Pool
By

By
Gilead Sciences has signed a licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to its human immunodeficiency virus (HIV) drug, bictegravir…

Sellas, Merck & Co. in Immunotherapy Pact
By

By
Merck & Co. has signed a clinical trial and supply agreement with Sellas Life Sciences, a Hamilton, Bermuda-headquartered biopharmaceutical company focused on cancer immunotherapies, to target multiple cancer types. Merck…

EMA Comments on Member States’ Proposals for HQ Relocation
By

By
The European Medicines Agency (EMA) has published information about its assessment of the 19 member states’ bids to host the agency, which is being relocated in the wake of the…

Avara Acquires AstraZeneca Solid-Dose Mfg Facility
By

By
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has agreed to acquire AstraZeneca’s secondary solid dosage form manufacturing, packaging, and distribution facility in Reims, France. This is the…

US Patent Office Rules In Lilly’s Favor On Alimta Vitamin Regime Patent
By

By
Eli Lilly and Company has won a victory in litigation initiated by Novartis’ generic arm, Sandoz, and Neptune Generics, a specialty and generics pharmaceutical company, regarding patentability of Lilly’s vitamin…

FDA Commissioner Addresses Potential Drug Shortages from Mfg in Puerto Rico
By

By
The US Food and Drug Administration’s (FDA’s) Commissioner Scott Gottlieb, MD, provided an update of the FDA’s efforts to track the impact of Puerto Rico’s medical-product manufacturing base following destruction…

Janssen Invests $350 Million in Ireland Biomanufacturing Facility
By

By
Janssen Sciences Ireland UC, part of Johnson & Johnson (J&J), is investing more than EUR 300 million ($354 million) to expand its biomanufacturing facility in Ringaskiddy, County Cork, Ireland. The…